Houston, TX – September 17th, 2025 – OmniScience, the AI company behind Vivo, the first agentic AI control tower for clinical trials, today announced its acceptance into the Fall 2025 cohort of the PharmStars Accelerator, the premier pharma-focused accelerator for digital health startups to improve patient outcomes.

PharmStars is the first and only digital health accelerator dedicated to advancing pharma–startup partnerships. Its mission is to bridge the “pharma–startup gap” by helping digital health companies better align with the needs of the pharmaceutical industry. Acceptance into PharmStars is highly selective, with participating companies gaining unparalleled access to pharma leaders, mentorship, and opportunities for collaboration. The Fall 2025 cohort is centered on the theme “Innovations in Data Management & Insights”.

“Our selection into PharmStars is a significant milestone for OmniScience,” said Angela Holmes, CEO and Co-Founder of OmniScience. “As clinical trial teams navigate rising complexity and pressure to deliver trials faster, our Vivo platform equips teams with unified data, real-time insights, and explainable AI to accelerate development to get more treatments to patients. PharmStars provides the ideal platform for us to expand collaborations and bring this value to more life sciences partners.”

Vivo is the first agentic AI platform purpose-built for clinical trial operations. Designed to reason like a clinical trial expert, Vivo unifies fragmented trial data, applies intelligent automation, and delivers proactive insights that reduce manual oversight and accelerate decision-making. With explainable AI and regulatory-grade auditability, Vivo transforms clinical operations, cutting manual effort by 60-70%, reducing costs by 20%, and accelerating clinical development.

Through PharmStars, OmniScience will join a cohort of digital health innovators working directly with pharma partners to address critical industry needs. The program culminates in the Pharmatech Innovation Summit, where participants present to an audience of pharma executives and potential collaborators. The Summit will showcase startups addressing pharma’s biggest challenges in managing vast amounts of data, applying AI effectively, and generating meaningful insights across the drug development lifecycle.